Navigation Links
Sangart Raises Additional $50M Series G Funding Following Interim Safety Analysis Of Phase 2b Study Of MP4OX In Severe Trauma Patients With Hemorrhagic Shock
Date:5/24/2012

SAN DIEGO, May 24, 2012 /PRNewswire/ -- Sangart, Inc., a global biopharmaceutical company dedicated to developing and commercializing targeted rescue therapies for patients in acute ischemic crisis, today announced that it recently received $50 million in additional equity funding from existing investor, Leucadia National Corporation. This funding was made upon the exercise of Series G preferred stock warrants previously held by Leucadia and brings the total funding raised by the company since inception to more than $280 million.

(Logo: http://photos.prnewswire.com/prnh/20120524/LA12228LOGO)

This funding followed an independent Data Monitoring Committee (DMC) review of safety data from the first 122 patients enrolled in the Phase 2b trauma study involving MP4OX, Sangart's novel oxygen therapeutic agent (OTA) developed to perfuse and oxygenate tissues at risk for ischemia in patients experiencing hemorrhagic shock. After evaluating the data, the DMC unanimously recommended that the study should continue without any modification.

"We are encouraged by this level of support from our existing investors, who recognize the clinical potential of our products," said Brian O'Callaghan, President and CEO of Sangart. "This funding will allow us to continue advancing the development of our medicines and get them as quickly as possible to patients in need. We continue to see promise in our unique MP4 gas-delivery platform, focused on developing therapies for patients in crisis who are experiencing ischemia and organ dysfunction as a result of hemorrhagic shock injury or a vaso-occlusive crisis associated with sickle cell disease."

The funds will be used to advance the development of the MP4OX product in severe traumatic hemorrhagic shock and the MP4CO product in sickle cell disease.  

About MP4
Sangart's unique MP4 gas-delivery platform is being used to dev
'/>"/>

SOURCE Sangart, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sangart, Inc. Receives $1.1 Million Grant Award from the United States Department of Defense for Further Development of MP4 Molecule in Trauma
2. Sangart, Inc. Reports Positive Phase IIa Data for Novel Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients
3. Sangart, Inc. Receives European Orphan Drug Designation for the Use of MP4CO in Patients With Sickle Cell Disease
4. Sangart, Inc. Completes Series F Funding Round
5. Sangart, Inc. Announces Key Executive Appointments and Company Restructuring
6. Cerecor Raises $22 Million Series A Financing
7. Biotech Firm Spun Off from Childrens Hospital Raises $7 Million to Advance Magnetic-Based Vascular Treatment
8. Cowen Healthcare Royalty Partners Raises $1 Billion
9. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
10. DLVR Therapeutics Inc. Raises Additional Capital Adding MaRS Innovation to Investor Base
11. Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... San Diego, CA (PRWEB) July 24, 2014 ... in the reporting of molecular diagnostic test results. ... tracking capabilities necessary for the validation and reporting ... in oncology. Molecular diagnostics is a rapidly growing ... for infectious disease, genetic predisposition, cancer, and companion ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 International research ... announced that its biobanking project, Provia Laboratories , ... its growing Advisory Board. Scott Wolf , CEO ... have Dr. Vaught onboard with Provia’s ever-expanding Advisory Board. ... that Provia’s management team brings to this field, should ...
(Date:7/23/2014)... great strides in saving China,s endangered national treasure, the ... giant panda reserves that have been established and three ... pandas remain in the wild. , Breeding programs ... panda by improving genetic diversity, avoid inbreeding and ultimately, ... these high-profile programs doing so far? , In a ...
(Date:7/23/2014)... the Vienna University of Technology and the Maria ... perfect semiconductor crystals into a silicon nanowire. With ... fast and multi-functional processing units can be accommodated ... research results will be published in the journal ... the cornerstone of future chip technology, but the ...
Breaking Biology Technology:New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 3Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 4A crystal wedding in the nanocosmos 2
... 1, 2003 at the Midwest Express Center inMilwaukee, Wisconsin, ... of migrating Microsoft Windows NT(R) 4.0 environments to WindowsServer ... connected, scalable,reliable platform that has been designed to meet ... problems. , , ,"We are very pleased to ...
... always, these are general rules, and any good entrepreneur will ... time, in the last 3.5 years weve received about 1,500 ... 100 detailed reviews, and participated in or facilitated more than ... seven rules on avoiding mistakes, and a final reminder of ...
... MADISON - A veteran television reporter recently asked me to ... expect to find jobs after they complete their education. The ... know, I would invest every penny I have in those ... Labor Day passes in Wisconsin, the question about jobs for ...
Cached Biology Technology:"For Angels Only...When to say No... 2"For Angels Only...When to say No... 3Heres how todays Wisconsin children will find jobs tomorrow 2Heres how todays Wisconsin children will find jobs tomorrow 3
(Date:7/24/2014)... An international team of researchers led by the University ... community-led marine conservation in the Western Indian Ocean. ... ONE , point to a revolution in the management ... sites more than 11,000 km in the ... areas (MPAs) are zones of the seas and coasts ...
(Date:7/24/2014)... in German . ... asthma sufferers worldwide, a further 600 million people living ... global population contending with allergic rhinitis (allergic inflammation of ... other organs and parts of the body beyond the ... the form of inflammatory bowel diseases such as colitis ...
(Date:7/24/2014)... is available in German . ... Norway and they are a common sight on the roads ... cars topped the list of new vehicle registrations for the ... in Germany, where electric vehicles claim only a small portion ... roads in Germany, only a mere 8000 are electric powered. ...
Breaking Biology News(10 mins):Western Indian Ocean communities play vital role in conservation 2New drugs to combat asthma and the like 2New drugs to combat asthma and the like 3Nano-supercapacitors for electric cars 2Nano-supercapacitors for electric cars 3
... President George Bush outlined his plan to reduce the nation's ... billion gallons a year of renewable and alternative fuels by ... of 7.5 billion gallons by 2012. , Among the most ... main biofuel used in the United States is ethanol distilled ...
... In his Jan. 23 State of the Union address, President ... on foreign oil by requiring the production of 35 billion ... roughly five times the current target set by Congress of ... alternatives are fuels derived from biological material. Currently, the main ...
... on the amount of salt in their diet could reduce their ... report on bmj.com today. , Researchers in Boston also ... death from cardiovascular disease by up to a fifth. ... to the heart or arteries, for example a stroke or heart ...
Cached Biology News:Custom-made cancer cell attacks 2Custom-made cancer cell attacks 3Cellulosic ethanol: Fuel of the future? 2Cellulosic ethanol: Fuel of the future? 3Eating less salt could prevent cardiovascular disease 2
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Umbilical cord blood basophils, For immunohistochemistry (IHC)...
Human peripheral blood neutrophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Human peripheral blood CD14+ monocytes, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Biology Products: